retatrutide status fda Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide FDA Approval Status 2026:

Reuben A Gittelman R, Gao J, Zhang J, Yusko E, Wu CJ, Emerson R, Chen R, Zhang J, Tipton C, Vence L, Cascone T, Vignali M, Fujimoto J, Rodriguez-Canales J, e P, Forget MA, Federico L, Haymaker C, Behren C, Benzeno S, Bernatchez C, Sepesi B, Gibbons D, Wargo J, Swisher SG , Heymach J, Robins H, Lee JJ, Sharma P, Allison J, Futreal PA, Wistuba I, Zhang J

After the reported ineffectiveness of lifestyle modifications combined with metformin therapy initiated at age 9, semaglutide treatment was started at age 13

Heres why this matters during GLP-1 weight loss: Counteract muscle loss

Author correction: Greengenes2 unifies microbial data in a single reference tree